EIND, OLE, RTT...those programs have been suspended while they focus on trials
During CD12 Severe/Critical trial last year, FDA actually required CYDY to discontinue eIND's.
So really this is the same thing after starting the next trial. Each of these individual requests requires a lot of time. It is disappointing that it's not currently available but also not unexpected